Back to Newsroom

UTHealth in Houston and Athersys Announce Funding for Clinical Trial using MultiStem® to Treat Trauma Patients

The University of Texas Health Science Center at Houston (UTHealth) and Athersys, Inc. (ATHX) today announced plans to conduct a Phase 2 clinical trial evaluating Athersys’ MultiStem® cell therapy for early treatment and prevention of complications after severe traumatic injury. This first-ever study of a cell therapy for treatment of a wide range of traumatic injuries will be conducted at Memorial Hermann-Texas Medical Center, one of the busiest Level 1 trauma centers in the United States.

Read More Here